A pilot study involving a new device which could help with facial plastic surgery has produced promising results.
The Endotine ST is used to stabilise soft tissue surrounding the cheekbone after the tissue has been lifted into a new position, according to Reuters news agency.
The procedure allows the volume of the fat pads over the cheeks to be redistributed, making it suitable for patients who are experiencing sagging in that area.
Nine out of ten patients on whom the device was trialled reported significant improvements in their appearance six months after the procedure, according to Dr James Newman of California's Stanford University Medical Centre.
Writing in the July/August edition of the Archives of Facial Plastic Surgery, Dr Newman reported that patients involved in the trial experienced less major swelling and nerve weakness than is normally found with traditional facelifts and none of the patients had infections, Reuters reports.
In addition, he wrote that the device made the likelihood of accidentally entrapping a nerve in a suture less likely.
Dr Newman commented: "The adjustability and decreased risk of nerve entrapment to the overlying soft tissues makes the Endotine ST device another option for safe and secure stabilisation of a properly mobilised midface."